SOLARA — Solara Active Pharma Sciences Share News
0.000.00%
- IN₹29.41bn
- IN₹34.56bn
- IN₹13.69bn
Brief: Solara Active Pharma Sciences Says Sept-Quarter Consol Net Profit 284.6 Million Rupees
Brief: Solara Active Pharma Sciences Says Tax Demand Of 1.62 Billion Rupees Reduced To Nil After Rectification
Brief: Solara Active Pharma Sciences June-Quarter Consol Net Profit 163.1 Million Rupees
Brief: Solara Active Pharma Sciences March-Quarter Consol Net Profit 96 Million Rupees
Brief: Solara Active Pharma Sciences Says Closure Of US FDA Inspection Of Puducherry Facility
Brief: Solara Active Pharma Sciences Dec-Quarter Consol Net Loss 174.3 Million Rupees
India's Solara Active Pharma plunges on posting quarterly loss
Brief: Solara Active Pharma Sciences Sept-Quarter Consol Net Loss 101 Million Rupees
India's Solara Active Pharma Sciences jumps on posting quarterly profit
Brief: Pronomz Ventures LLP Buys 2 Mln Shares In Solara Active Pharma Sciences Via Bulk Deal - NSE Data
India's Solara Active Pharma gains on clean chit from US FDA
India's Shilpa Medicare gains after over 11-fold rise in Q2 profit
India's Solara Active Pharma extends gains on posting Q2 profit
India's Solara Active Pharma snaps 9-day rally as TPG cuts stake
Brief: Solara Active Pharma Sciences Announced Closure Of Its Rights Issue For Raising Funds Upto 4.5 Bln Rupees
India's Solara Active Pharma up after USFDA inspection ends
Brief: Solara Active Pharma Sciences Says Solara Visakhapatnam Facility Completes USFDA Inspection
Brief: Solara Active Pharma Sciences Approved Rights Issue Price
Brief: Solara Active Pharma Sciences Approves Sale Of 100% Shareholding In Sequent Penems